Results 31 to 40 of about 2,537 (171)

Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study

International Journal of Infectious Diseases, 2023
Objectives: We examined the safety and clinical outcomes of outpatient parenteral antibiotic therapy (OPAT) for patients with infective endocarditis (IE) in Christchurch, New Zealand.
Patrick O. Campbell, Kate Gallagher, Simon C. Dalton, Sarah C.L. Metcalf, Nicholas M. Douglas, Stephen T. Chambers   +5 more
doaj   +1 more source

Review of the first comprehensive outpatient parenteral antimicrobial therapy program in a tertiary care hospital in Japan

International Journal of Infectious Diseases, 2020
Objectives: The infectious diseases team at Kameda Medical Center, Japan, implemented a new outpatient parenteral antimicrobial therapy (OPAT) program in July 2012 and expanded the program with the support of home care services.
Ryota Hase, Yoshiaki Yokoyama, Hiroyuki Suzuki, Shunsuke Uno, Takahiro Mikawa, Daisuke Suzuki, Kiyoharu Muranaka, Naoto Hosokawa   +7 more
doaj   +1 more source

Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation

BMC Infectious Diseases, 2021
Objectives An estimated 1% of endovascular aneurysm repair (EVAR) devices become infected, carrying a high mortality rate. Surgical explantation is recommended and prognosis is guarded. This retrospective cohort analysis focuses on the role of outpatient
Niamh Allen, Mohamed Adam, Grace O’Regan, Aoife Seery, Cora McNally, Samuel McConkey, Aisling Brown, Eoghan de Barra   +7 more
doaj   +1 more source

Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses

BMJ Open, 2021
Objectives To compare costs associated with different models of outpatient parenteral antimicrobial therapy (OPAT) delivery with costs of inpatient (IP) care across key infection groups managed via OPAT in the UK.Design A cost-minimisation design was ...
Mark Gilchrist, Maria Dimitrova, R A Seaton   +2 more
doaj   +1 more source

339. OPAT Outcomes in Patients with Immunocompromise

Open Forum Infectious Diseases, 2023
Abstract Background Outpatient parenteral antimicrobial therapy (OPAT) allows patients to complete intravenous (IV) or high risk oral medications outside the acute inpatient setting. Data regarding OPAT in patients with immunocompromise (PWIC) are sparse.
Mahoney, Monica V, Swords, Kyleen, Le Mahajan, Audrey, Alonso, Carolyn D, Larnard, Jeffrey   +4 more
openaire   +1 more source

Outpatient parenteral antibiotic therapy in a renal transplant population: A single-center experience

Saudi Journal of Kidney Diseases and Transplantation, 2015
Outpatient parenteral antimicrobial therapy (OPAT) is a well-established method in medical specialties. Its use in renal transplant recipients has not been thoroughly explored. No guidelines within this patient subset exist.
Jade Harrison, Mohammad Ayaz Hossain, Mohamed Morsy, Abbas Ghazanfar   +3 more
doaj   +1 more source

An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy

Therapeutic Advances in Infectious Disease, 2023
Background: Outpatient parenteral antimicrobial therapy (OPAT), when required, is beneficial to patients and healthcare systems by reducing hospital length-of-stay, providing cost savings, and improving patient satisfaction.
Abby C. Bradley, Mary Joyce B. Wingler, Katherine L. Artman, Lori M. Ward, Jose Lucar   +4 more
doaj   +1 more source

A rare complication of otitis media: Gradenigo's syndrome successfully managed on outpatient antimicrobial therapy

Clinical Infection in Practice, 2020
We report a case of Gradenigo's syndrome successfully managed on an outpatient parenteral antibiotic service. This condition is classically described as a triad of otorrhoea, facial pain in the distribution of the trigeminal nerve and ipsilateral ...
Conor Bowman, Nada Nakhla, Victoria Amedu, Parag Patel, Ciara O'Connor, Angela Houston, Aodhan Breathnach   +6 more
doaj   +1 more source

Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers

Therapeutic Advances in Infectious Disease, 2023
Background: Outpatient Parenteral Antimicrobial Therapy (OPAT) is considered a patient-friendly and cost-effective practice. Patients in the OPAT service can be at risk for developing adverse events.
Moska Hassanzai, Fadime Adanç, Birgit C P Koch, Nelianne J Verkaik, Jakob van Oldenrijk, Jorg L de Bruin, Brenda C M de Winter, Hein A W van Onzenoort   +7 more
doaj   +1 more source

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis

Heliyon, 2023
Patients with bronchiectasis often require hospitalisation for the administration of intravenous antibiotics for the management of acute exacerbations. Increasingly, Outpatient Parenteral Antibiotic Therapy (OPAT) services have become available as a potential alternative for domiciliary management.This study assessed outcomes in both cystic fibrosis ...
Jacky Tu, Mohammed Al Harasi, Michael Pallin, Chris Daley, Benjamin A. Rogers, Paul T. King   +5 more
openaire   +3 more sources